Literature DB >> 29896316

Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.

Holger Fröhlich1, Sabyasachi Patjoshi1, Kristina Yeghiazaryan2,3,4, Christina Kehrer3,4,5, Walther Kuhn3,4,5, Olga Golubnitschaja2,3,4.   

Abstract

BACKGROUND: The breast cancer (BC) epidemic is a multifactorial disease attributed to the early twenty-first century: about two million of new cases and half a million deaths are registered annually worldwide. New trends are emerging now: on the one hand, with respect to the geographical BC prevalence and, on the other hand, with respect to the age distribution. Recent statistics demonstrate that young populations are getting more and more affected by BC in both Eastern and Western countries. Therefore, the old rule "the older the age, the higher the BC risk" is getting relativised now. Accumulated evidence shows that young premenopausal women deal with particularly unpredictable subtypes of BC such as triple-negative BC, have lower survival rates and respond less to conventional chemotherapy compared to the majority of postmenopausal BC. WORKING HYPOTHESIS: Here we hypothesised that a multi-level diagnostic approach may lead to the identification of a molecular signature highly specific for the premenopausal BC. A multi-omic approach using machine learning was considered as a potent tool for stratifying patients with benign breast alterations into well-defined risk groups, namely individuals at high versus low risk for breast cancer development. RESULTS AND
CONCLUSIONS: The study resulted in identifying multi-omic signature specific for the premenopausal BC that can be used for stratifying patients with benign breast alterations. Our predictive model is capable of discriminating individually between high and low BC-risk with high confidence (>90%) and considered of potential clinical utility. Novel risk assessment approaches and advanced screening programmes-as the long-term target of this project-are of particular importance for predictive, preventive and personalised medicine as the medicine of the future, due to the expected health benefits for young subpopulations and the healthcare system as a whole.

Entities:  

Keywords:  Bioinformatics; Biomarker panel; Breast cancer; Laboratory medicine; Machine learning; Menopause; Multi-level diagnostics; Patient stratification; Predictive preventive personalised medicine

Year:  2018        PMID: 29896316      PMCID: PMC5972143          DOI: 10.1007/s13167-018-0131-0

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  40 in total

1.  Metagenes and molecular pattern discovery using matrix factorization.

Authors:  Jean-Philippe Brunet; Pablo Tamayo; Todd R Golub; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

2.  Breast cancer incidence trends in European women aged 20-39 years at diagnosis.

Authors:  D F Merlo; M Ceppi; R Filiberti; V Bocchini; A Znaor; M Gamulin; M Primic-Žakelj; P Bruzzi; C Bouchardy; A Fucic
Journal:  Breast Cancer Res Treat       Date:  2012-03-29       Impact factor: 4.872

3.  Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.

Authors:  Rebecca H Johnson; Franklin L Chien; Archie Bleyer
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

4.  DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes.

Authors:  Olga Golubnitschaja; Heike Moenkemann; Kerstin Kim; Mahmood S Mozaffari
Journal:  Biochem Pharmacol       Date:  2003-08-01       Impact factor: 5.858

5.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

6.  Cancer incidence in egypt: results of the national population-based cancer registry program.

Authors:  Amal S Ibrahim; Hussein M Khaled; Nabiel Nh Mikhail; Hoda Baraka; Hossam Kamel
Journal:  J Cancer Epidemiol       Date:  2014-09-21

7.  Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Authors:  Natalie J Engmann; Marzieh K Golmakani; Diana L Miglioretti; Brian L Sprague; Karla Kerlikowske
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

8.  Recent increase of breast cancer incidence among women under the age of forty.

Authors:  C Bouchardy; G Fioretta; H M Verkooijen; G Vlastos; P Schaefer; J-F Delaloye; I Neyroud-Caspar; S Balmer Majno; Y Wespi; M Forni; P Chappuis; A-P Sappino; E Rapiti
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

9.  Intermittent energy restriction induces changes in breast gene expression and systemic metabolism.

Authors:  Michelle N Harvie; Andrew H Sims; Mary Pegington; Katherine Spence; Adam Mitchell; Andrew A Vaughan; J William Allwood; Yun Xu; Nicolas J W Rattray; Royston Goodacre; D Gareth R Evans; Ellen Mitchell; Debbie McMullen; Robert B Clarke; Anthony Howell
Journal:  Breast Cancer Res       Date:  2016-05-28       Impact factor: 6.466

10.  Risk assessment model for invasive breast cancer in Hong Kong women.

Authors:  Feng Wang; Juncheng Dai; Mengjie Li; Wing-Cheong Chan; Carol Chi-Hei Kwok; Siu-Lan Leung; Cherry Wu; Wentao Li; Wai-Cho Yu; Koon-Ho Tsang; Sze-Hong Law; Priscilla Ming-Yi Lee; Carmen Ka-Man Wong; Hongbing Shen; Samuel Yeung-Shan Wong; Xiaohong R Yang; Lap Ah Tse
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more
  21 in total

Review 1.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

Review 2.  Dietary phytochemicals as the potential protectors against carcinogenesis and their role in cancer chemoprevention.

Authors:  Alena Liskova; Patrik Stefanicka; Marek Samec; Karel Smejkal; Pavol Zubor; Tibor Bielik; Kristina Biskupska-Bodova; Taeg Kyu Kwon; Jan Danko; Dietrich Büsselberg; Mariusz Adamek; Luis Rodrigo; Peter Kruzliak; Aleksandr Shleikin; Peter Kubatka
Journal:  Clin Exp Med       Date:  2020-02-03       Impact factor: 3.984

3.  Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients.

Authors:  Maode Bao; Run Shi; Kai Zhang; Yanbo Zhao; Yanfang Wang; Xuanwen Bao
Journal:  EPMA J       Date:  2019-11-07       Impact factor: 6.543

Review 4.  Human disease biomarker panels through systems biology.

Authors:  Bradley J Smith; Licia C Silva-Costa; Daniel Martins-de-Souza
Journal:  Biophys Rev       Date:  2021-10-13

Review 5.  Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention.

Authors:  A Kapinova; P Kubatka; O Golubnitschaja; M Kello; P Zubor; P Solar; M Pec
Journal:  Environ Health Prev Med       Date:  2018-08-09       Impact factor: 3.674

6.  Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.

Authors:  Hai-Yun Zhao; Yue Gong; Fu-Gui Ye; Hong Ling; Xin Hu
Journal:  Cancer Manag Res       Date:  2018-11-20       Impact factor: 3.989

Review 7.  Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management.

Authors:  Pavol Zubor; Peter Kubatka; Karol Kajo; Zuzana Dankova; Hubert Polacek; Tibor Bielik; Erik Kudela; Marek Samec; Alena Liskova; Dominika Vlcakova; Tatiana Kulkovska; Igor Stastny; Veronika Holubekova; Jan Bujnak; Zuzana Laucekova; Dietrich Büsselberg; Mariusz Adamek; Walther Kuhn; Jan Danko; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

Review 8.  DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.

Authors:  Karin Jasek; Peter Kubatka; Marek Samec; Alena Liskova; Karel Smejkal; Desanka Vybohova; Ondrej Bugos; Kristina Biskupska-Bodova; Tibor Bielik; Pavol Zubor; Jan Danko; Marian Adamkov; Taeg Kyu Kwon; Dietrich Büsselberg
Journal:  Biomolecules       Date:  2019-07-18

9.  Platelet Volume Is Reduced In Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts.

Authors:  Ming-Ming Li; Chen-Xi Yue; Shuang Fu; Xin Zhang; Chang-Jiu Zhao; Rui-Tao Wang
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

10.  Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations.

Authors:  Elisha Goldstein; Kristina Yeghiazaryan; Ashar Ahmad; Frank A Giordano; Holger Fröhlich; Olga Golubnitschaja
Journal:  EPMA J       Date:  2020-08-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.